With deep roots in health care, manufacturing and information technology, southwestern Pennsylvania created a foundation for a diversity of companies in the life sciences sector. From health IT to devices to therapeutics, the region has become recognized as a center of innovation. Here’s a sample of what’s growing in Pittsburgh:
Stroke is the number one leading cause of disability in the United States, and this is most often because of delay in diagnosis and treatment. Time is brain. In fact, 50% of all stroke patients (400,000 per year) are initially taken to hospitals that can’t adequately treat and manage stroke. They then must be transferred to a stroke center, and this causes an average delay of 110 minutes. These delays increase costs by about $50B each year. Forest Devices is a Pittsburgh medical device company that has created AlphaStroke, an easy to use device that can detect stroke in the ambulance. Forest Devices is getting stroke patients to the right hospital faster.
The mission of TeleTracking is simple: no patient should ever have to wait for the care they need. As a world leader in patient flow solutions, TeleTracking is more than a health care technology company. Industry experts, process consultants and thought leaders in the health care space, TeleTracking is delivering reportable and proven outcomes impacting hospitals and healthcare systems all over the world.
TeleTracking began more than 25 years ago as a solution to solve the bed turnover problem using what was found in every patient room: a telephone. Expanding, growing and changing, now with a portfolio of end-to-end patient flow software solutions, and proven best practices, the name TeleTracking describes the journey of the past, present and future.
Promethean is the leader in processing human skin allograft for use as a sterile medical product. Promethean’s initial product, GammaGraft®, is the first irradiated human skin allograft storable at ambient temperature. Repriza®, a sterile Acellular Dermal Matrix, is an excellent graft for reinforcing the abdominal wall during hernia surgery or as a bolster for breast reconstruction following mastectomy.
Human skin allograft has long been considered the Gold Standard for wound care. Most health care professionals, outside of regional burn centers, have not had access to human skin allograft. At last there is a human skin Allograft that is storable at ambient temperature and ready for application upon opening a foil pouch. This allows physicians everywhere to benefit from the use of allograft skin.
Net Health is the leader in software solutions for specialized outpatient care. Known for being experts in The Art of the Right Fit®, its fully interoperable EMR solutions serve five medical specialty markets and offer clients an end-to-end solution that includes practice management tools, clinical workflow documentation, RCM, expert coaching, and analytics.
Net Health serves health care professionals in 98% of the largest hospital chains in the U.S., as well as private practices around the country—driving workflow in more than 3,000 urgent care, wound care, physical therapy, speech and language therapy, occupational therapy, occupational medicine, employee health and workplace medicine facilities each day. Net Health is a portfolio company of The Carlyle Group and Level Equity. Net Health is committed to strengthening patient care, outcomes and facility performance.
As a global leader in the sleep and respiratory markets, Philips is passionate about providing solutions that lead to healthier patients, practices and businesses. For Philips, innovation in sleep apnea management, oxygen therapy, noninvasive ventilation and respiratory drug delivery is driven by gaining insight into the needs of our customers. The company announced building an expanded presence in Pittsburgh’s East End at Bakery Square.
AbiliLife engineers products to improve the quality of life for neurodegenerative and elderly patients. Courtney Williamson, CEO and Founder, has personal experience with neurodegenerative diseases as she was a caregiver for her mother who had Parkinson’s disease for 25 years. Williamson developed the concept for the Calibrace+ while pursuing doctoral studies at Carnegie Mellon University.
For over three decades, Neuro Kinetics (NKI) has supplied comprehensive neuro-functional diagnostic and assessment tools to neurologists, audiologists, scientists, researchers, ENT’s, neurotologists and neuro-ophthalmologists around the globe. Bottom line — No company has been more integral to the development of:
Clinical eye tracking;
• Non-invasive oculomotor and vestibular science; and
• The advancement of neuro-functional testing.
NKI’s mission is to translate advances in neuro-functional science to the clinic for improved patient care and outcomes. NKI’s I-Portal® technology is a foundational platform helping clinicians detect multiple medical conditions early, accurately and cost effectively.
I-Portal technology is a highly functional, non-invasive, diagnostic measurement tool that can detect deficits associated with scores of medical conditions at low cost, and, in many cases, earlier than, invasive technologies. Leading edge science is enabling NKI to expand its presence from its historic vestibular market into new arenas and applications in traumatic brain injury, concussion, ophthalmology and neurology.